Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking and inflammatory bowel disease. A case control study.

E Lindberg1, C Tysk, K Andersson

  • 1Department of Medicine, Orebro Medical Center Hospital, Sweden.

Gut
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sinonasal outcome test-22 and peak nasal inspiratory flow - valuable tools in obstructive sleep apnoea.

Rhinology·2020
Same author

Kinase-templated abiotic reaction.

Chemical science·2017
Same author

Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.

BMC gastroenterology·2017
Same author

Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema.

The British journal of dermatology·2016
Same author

Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease - authors' reply.

Alimentary pharmacology & therapeutics·2016
Same author

The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2016

Smoking decreases ulcerative colitis risk but doubles Crohn's disease risk. Former smokers, especially heavy ones, face a significantly higher ulcerative colitis risk due to a rebound effect.

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • Smoking is a known environmental factor influencing inflammatory bowel diseases (IBD).
  • The distinct effects of smoking on ulcerative colitis (UC) and Crohn's disease (CD) require further population-based investigation.
  • Understanding smoking's role is crucial for IBD prevention and management strategies.

Purpose of the Study:

  • To investigate the association between smoking habits and the risk of developing ulcerative colitis and Crohn's disease.
  • To examine dose-dependent effects and the impact of smoking cessation on IBD risk.
  • To identify potential sex-based differences in these associations.

Main Methods:

  • A population-based case-controlled study design was employed.

Related Experiment Videos

  • Data collected from 260 ulcerative colitis patients and 144 Crohn's disease patients.
  • Smoking status (current, former, never) at diagnosis was assessed and compared between cases and controls.

    • Main Results:

    • Current smokers exhibited a reduced risk of ulcerative colitis (relative risk 0.7), appearing dose-dependent.
    • Former smokers, particularly former heavy smokers, showed a significantly increased risk of ulcerative colitis (relative risk 4.4).
    • Smoking doubled the risk of Crohn's disease without a clear dose-dependent pattern; former smokers had a non-significantly increased risk.

    Conclusions:

    • Smoking appears to be protective against ulcerative colitis onset but increases Crohn's disease risk.
    • Smoking cessation may lead to a rebound effect, increasing ulcerative colitis risk, especially in heavy former smokers.
    • These findings highlight the complex and differential impact of smoking on IBD subtypes.